Category:
Other Preparations
Standard:
N;
Pramipexole Dihydrochloride Extended-Release Tablets is a dopamine agonist of the non-ergoline class indicated for treating Parkinson's disease (PD)[1] and restless legs syndrome (RLS).
It is still in R&D stage.
Pramipexole Dihydrochloride Extended-Release Tablets are pharmaceutical formulations designed for sustained dopamine agonist delivery. Manufacturing utilizes controlled-release polymer matrices to ensure consistent plasma concentration over 24 hours.